https://www.selleckchem.com/pr....oducts/muramyl-dipep
There has been no consensus on whether and how long add-on drugs for augmentation therapy should be continued in the treatment of depression. Double-blind randomized controlled trials that examined the effects of discontinuation of drugs used for augmentation on treatment outcomes in patients with depression were identified. Meta-analyses were performed to compare rates of study withdrawal due to any reason, study-defined relapse, and adverse events between patients who continued augmentation therapy and those who discontinued
Like
Comment
Share
